Inventor · disambiguated record
Brian Edward Vash
Also filed as: VASH BRIAN · VASH BRIAN EDWARD
18 granted patents·23 pending applications·74 citations·filing 2010–2025
92Inventor score
Top patents by PatentIndex Score
41 records- 0196US11291721B2Multispecific and multifunctional molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2017·Granted Apr 5, 2022·15 cites·22 claims
- 0295US11965025B2Method of treating solid cancers with bispecific interleukin-anti-TCRß moleculesMARENGO THERAPEUTICS INC·Filed 2022·Granted Apr 23, 2024·7 cites·26 claims
- 0394US10287354B2Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2014·Granted May 14, 2019·29 cites·63 claims
- 0493US11845797B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2019·Granted Dec 19, 2023·7 cites·34 claims
- 0592US12351632B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2023·Granted Jul 8, 2025·1 cites·33 claims
- 0691US12486326B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2023·Granted Dec 2, 2025·1 cites·10 claims
- 0791US12286477B2Anti-TCR antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2022·Granted Apr 29, 2025·1 cites·29 claims
- 0886US2024301060A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0984US12152073B2Multifunctional molecules that bind to calreticulin and uses thereofMARENGO THERAPEUTICS INC·Filed 2019·Granted Nov 26, 2024·4 cites·20 claims
- 1083US12384842B2Antibody molecules that bind to NKP30 and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Granted Aug 12, 2025·1 cites·23 claims
- 1183US11578130B2Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2018·Granted Feb 14, 2023·1 cites·30 claims
- 1282US2025340640A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1380US12247060B2Calreticulin binding constructs and engineered T cells for the treatment of diseasesMARENGO THERAPEUTICS INC·Filed 2019·Granted Mar 11, 2025·1 cites·24 claims
- 1478US2025215085A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 1577US2022064297A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1675US9512199B2Fibronectin cradle molecules and libraries thereofLOEW ANDREAS·Filed 2011·Granted Dec 6, 2016·3 cites·5 claims
- 1774US11673971B2Multispecific antibody molecules comprising lambda and kappa light chainsMARENGO THERAPEUTICS INC·Filed 2017·Granted Jun 13, 2023·1 cites·10 claims
- 1874US2025074998A1Multifunctional molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1972US12421323B2Multispecific antibody molecules comprising lambda and kappa light chainsMARENGO THERAPEUTICS INC·Filed 2023·Granted Sep 23, 2025·0 cites·13 claims
- 2072US2023026049A1Regulatable chimeric antigen receptorNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2170US2023227552A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2269US2022378833A1Dimerization switches and uses thereofNOVARTIS AG·Filed 2022·Application pending·0 cites
- 2367US9139825B2Universal fibronectin type III bottom-side binding domain librariesLOEW ANDREAS·Filed 2010·Granted Sep 22, 2015·2 cites·12 claims
- 2466US2022288200A1Multispecific and multifunctional molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2563US2025333500A1Multifunctional molecules that bind to t cell related cancer cells and uses thereofMARENGO THERAPEUTICS INC·Filed 2025·Application pending·0 cites
- 2661US12358982B2Multifunctional molecules that bind to T cell related cancer cells and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Granted Jul 15, 2025·0 cites·23 claims
- 2759US2021380692A1Anti-tcr antibody molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 2858US2025263473A1Bispecific binding agentTHE FRANCIS CRICK INSTITUTE LTD·Filed 2023·Application pending·0 cites
- 2956US10253313B2Universal fibronectin type III bottom-side binding domain librariesLOEW ANDREAS·Filed 2015·Granted Apr 9, 2019·0 cites·12 claims
- 3053US2020181216A1Hsa-gdf-15 fusion polypeptide and use thereofNOVARTIS AG·Filed 2019·Application pending·0 cites
- 3152US2021380670A1Multifunctional molecules that bind to calreticulin and uses thereofMARENGO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3251US2021380691A1Multifunctional molecules that bind to t cells and uses thereof to treat autoimmune disordersMARENGO THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 3348US2019054117A1Dimerization switches and uses thereofLOEW ANDREAS·Filed 2015·Application pending·0 cites
- 3447US2021009711A1Multifunctional molecules and uses thereofELSTAR THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3546US2022242957A1Csf1r/ccr2 multispecific antibodiesMARENGO THERAPEUTICS INC·Filed 2019·Application pending·0 cites
- 3644US12134654B2Multispecific molecules and uses thereofMARENGO THERAPEUTICS INC·Filed 2018·Granted Nov 5, 2024·0 cites·12 claims
- 3743US2020377571A1Multispecific molecules and uses thereofELSTAR THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3843US2021246227A1Multispecific molecules that bind to myeloproliferative leukemia (mpl) protein and uses thereofELSTAR THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 3941US2020385472A1Multispecific molecules comprising a non-immunoglobulin heterodimerization domain and uses thereofELSTAR THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4041US2020291089A1Multifunctional molecules comprising a trimeric ligand and uses thereofELSTAR THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 4140US2017204149A1Hsa-gdf-15 fusion polypeptide and use thereofCHOPRA RAJIV·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Brian Edward Vash files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →